PMI Biopharma Solutions, LLC – Trademark Portfolio
Entity Type: 16
PMI Biopharma Solutions, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AUGUST BIOSERVICES. The owner is based in Nashville, TN.
1845 Elm Hill Pike
Nashville, TN 37210
Showing of trademarks Trademarks
Trademark Classifications
PMI Biopharma Solutions, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does PMI Biopharma Solutions, LLC have?
PMI Biopharma Solutions, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does PMI Biopharma Solutions, LLC file in?
PMI Biopharma Solutions, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PMI Biopharma Solutions, LLC's most well-known trademarks?
PMI Biopharma Solutions, LLC's registered trademark portfolio includes well-known marks such as AUGUST BIOSERVICES. These are among 1 currently registered trademark in the portfolio.
What is PMI Biopharma Solutions, LLC's trademark registration success rate?
PMI Biopharma Solutions, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.